Liftstream is an executive search recruitment company in the life sciences sector
Open Innovation could spur diversity
Authored by Karl Simpson
Posted in General, Pharmaceutical business, Workplace Diversity
Tagged Berkeley, biomarkers, biotechnology, business, china, Diversity, Finland, Haas Business School, Henry Chesbrough, innovation, innovation black hole, Karl Simpson, manufacturing, medicine, Open Innovation, pharmaceutical executive, pharmaceuticals, R&D, research, research and development, South America, University of California
Leave a comment
Soriot to apply therapy to AstraZeneca
On 26th of April 2012 David Brennan stepped down as AstraZeneca’s CEO after 6 years in the job. David Brennan had risen through the ranks at AstraZeneca first at Astra and later after the merger with ICI spin-off Zeneca. Brennan had been criticised by investors for failing to sure up the companies pipeline as a wave of patents expired. Yet, when Brennan announced he was leaving, AstraZeneca’s share price fell dramatically and took nearly two months to recover.
Posted in Pharmaceutical business
Tagged Amylin, Andrew Witty, AstraZeneca, Biologics, business, CEO, David Brennan, Genentech, GSK, Liftstream, M&A, MedImmune, mega-merger, Pascal Soriot, Pipeline, Roche, Simon Lowth, Soriot, UK
2 Comments